Cargando…
Polymorphisms within the adenosine receptor 2a gene are associated with adverse events in RA patients treated with MTX
Objective. To examine the role of adenosine receptor 2a gene (ADORA2a) polymorphisms on outcome of MTX treatment in RA. Methods. Subjects included 309 RA patients with a defined response to MTX. Patients were included if they were (i) good responders (n = 147) (ESR <20 for >6/12 on stable dose...
Autores principales: | Hider, S. L., Thomson, W., Mack, L. F., Armstrong, D. J., Shadforth, M., Bruce, I. N. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2468887/ https://www.ncbi.nlm.nih.gov/pubmed/18539621 http://dx.doi.org/10.1093/rheumatology/ken182 |
Ejemplares similares
-
MMP-3 as a predictor for structural remission in RA patients treated with MTX monotherapy
por: Shiozawa, Kazuko, et al.
Publicado: (2016) -
Pragmatic randomised controlled trial of very early etanercept and MTX versus MTX with delayed etanercept in RA: the VEDERA trial
por: Emery, Paul, et al.
Publicado: (2020) -
Glycosylation-related gene expression in HT29-MTX-E12 cells upon infection by Helicobacter pylori
por: Cairns, Michael T, et al.
Publicado: (2017) -
Identification of 7 Proteins in Sera of RA Patients with Potential to Predict ETA/MTX Treatment Response
por: Obry, Antoine, et al.
Publicado: (2015) -
Treatment of methotrexate (MTX) intolerance: behavioural therapy, versus switch to parenteral MTX versus oral MTX
por: Verkaaik, M, et al.
Publicado: (2011)